Mariam E Sunny

4 weeks ago | dagenspharma.dk | Chandni Shah |Mariam E Sunny |Christy Santhosh

Moderna COVID vaccine approved for those 12-64 with risk factorsModerna expects mNEXSPIKE to be ready for 2025-2026 seasonVaccine easier to distribute in developing countriesMay 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's (MRNA.O), opens new tab next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements.

Mar 24, 2025 | risingnepaldaily.com | Mariam E Sunny |Kamal Choudhury

By Mariam E Sunny and Kamal Choudhury, March 24: Tuberculosis (TB) infections among children in the European region rose 10% in 2023, indicating ongoing transmission and the need for immediate public health measures to control the spread, the World Health Organization said on Monday. WHO's European region, which comprises 53 countries in Europe and Central Asia, reported more than 7,500 cases among children under 15 years of age in 2023, an increase of over 650 cases compared to 2022.

Mar 8, 2024 | reuters.com | Mariam E Sunny

March 8 (Reuters) - Amylyx Pharmaceuticals (AMLX.O), opens new tab is considering withdrawing its treatment for amyotrophic lateral sclerosis from the market after the drug failed to slow disease progression in a late-stage trial, sending its shares crashing 85% on Friday. The company said it would stop promotions of the drug and decide on its future in coming weeks after discussions with regulators. Meanwhile, the drug will be available at this time.

Mar 7, 2024 | reuters.com | Mariam E Sunny

The headquarters of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009/ File Photo March 7 (Reuters) - The U.S. Food and Drug Administration has granted accelerated approval for the expanded use of BeiGene's (6160.HK), opens new tab combination drug to treat certain patients with a type of blood cancer, the health regulator said on Thursday.

Mar 3, 2024 | today.westlaw.com | Shinjini Ganguli |Anil D'Silva |Mariam E Sunny

(Reuters) -Walgreens Boots Alliance's CEO rejected a media report, saying the company does not plan to sell specialty pharmacy unit Shields Health Solutions at least for nowThe pharmacy chain is instead looking for ways to drive "the most value" for...